OR WAIT null SECS
November 02, 2010
Post recession and beyond, which contract service providers will still be standing?
The authors present an update to the Wyeth/BASF experience with the IPEC Novel Excipient Safety Evaluation Procedure.
Stuart Needleman, president of active-ingredient development and manufacturing at Aptuit, discusses industry trends and challenges.
October 28, 2010
PPD and Bend Research Form Collaboration; Ricerca Makes Senior Appointment; And More.
October 21, 2010
Pfizer Forms Pact with Biocon; Baxter Makes Appointments; And More.
October 14, 2010
sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.
October 07, 2010
Company and People Notes: Novartis Settles with US Attorney's Office; Hospira Names VP, And More.
October 02, 2010
The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.
A recently released industry guide outlines a science- and risk-based approach to control the risk of cross-contamination.
Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.